[Evaluation of the hypotensive effect of captopril]. 1988

J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk
May 1983, British medical journal (Clinical research ed.),
J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk
April 1983, British medical journal (Clinical research ed.),
J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk
January 1986, Clinical and experimental hypertension. Part A, Theory and practice,
J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk
January 1985, Journal of cardiovascular pharmacology,
J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk
January 1988, Kardiologia polska,
J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk
September 1980, European journal of pharmacology,
J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk
November 1983, Methods and findings in experimental and clinical pharmacology,
J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk
February 1990, Hypertension (Dallas, Tex. : 1979),
J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk
October 1984, The Tohoku journal of experimental medicine,
J Hanzlik, and W Sodolski, and A Wojnicz, and S Ostrowski, and W Klimczak, and A Krawczyk
November 1981, Clinical science (London, England : 1979),
Copied contents to your clipboard!